Loading...
Cosmos Health Inc.
COSM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.70
$0.11(18.11%)
Cosmos Health Inc. (COSM) Financial Performance & Income Statement Overview
Review Cosmos Health Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.97%
↑ 1.97%
Operating Income Growth
28.80%
↑ 28.80%
Net Income Growth
12.73%
↑ 12.73%
Operating Cash Flow Growth
50.65%
↑ 50.65%
Operating Margin
-27.15%
↓ 27.15%
Gross Margin
9.39%
↑ 9.39%
Net Profit Margin
-28.26%
↓ 28.26%
ROE
-51.49%
↓ 51.49%
ROIC
-47.51%
↓ 47.51%
Cosmos Health Inc. (COSM) Income Statement & Financial Overview
Review Cosmos Health Inc.'s (COSM) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $13.71M | $14.22M | $12.41M | $13.21M |
| Cost of Revenue | $11.66M | $13.22M | $11.20M | $12.44M |
| Gross Profit | $2.05M | $1.004M | $1.21M | $767248.00 |
| Gross Profit Ratio | $0.15 | $0.07 | $0.10 | $0.06 |
| R&D Expenses | $15629.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.51M | $8.83M | $3.14M | $2.96M |
| Operating Expenses | $2.88M | $9.97M | $3.45M | $3.27M |
| Total Costs & Expenses | $14.55M | $23.19M | $14.65M | $15.71M |
| Interest Income | $91326.00 | $97418.00 | $101236.00 | $102030.00 |
| Interest Expense | -$187107.00 | $319767.00 | $181429.00 | $342446.00 |
| Depreciation & Amortization | $320439.00 | $312238.00 | $304139.00 | $313074.00 |
| EBITDA | -$512706.00 | -$8.38M | -$1.70M | -$1.94M |
| EBITDA Ratio | -$0.04 | -$0.59 | -$0.14 | -$0.15 |
| Operating Income | -$833145.00 | -$8.97M | -$2.24M | -$2.50M |
| Operating Income Ratio | -$0.06 | -$0.63 | -$0.18 | -$0.19 |
| Other Income/Expenses (Net) | $15048.00 | -$576251.00 | $57330.00 | -$88685.00 |
| Income Before Tax | -$818097.00 | -$9.54M | -$2.18M | -$2.59M |
| Income Before Tax Ratio | -$0.06 | -$0.67 | -$0.18 | -$0.20 |
| Income Tax Expense | $0.00 | $6.20M | $0.00 | $0.00 |
| Net Income | -$818097.00 | -$9.54M | -$2.18M | -$2.59M |
| Net Income Ratio | -$0.06 | -$0.67 | -$0.18 | -$0.20 |
| EPS | -$0.03 | -$0.50 | -$0.45 | -$0.15 |
| Diluted EPS | -$0.03 | -$0.50 | -$0.45 | -$0.15 |
| Weighted Avg Shares Outstanding | $26.04M | $19.15M | $18.42M | $17.83M |
| Weighted Avg Shares Outstanding (Diluted) | $26.04M | $19.15M | $18.42M | $17.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan